Herpes infections in breast cancer patients treated with adjuvant chemotherapy

Oncology

Volumn 71, Issue 3-4, 2007, Pages 164-167

  Masci, Giovanna ^a   Magagnoli, Massimo ^a   Gullo, Giuseppe ^a   Morenghi, Emanuela ^a   Garassino, Isabella ^a   Simonelli, Matteo ^a   Santoro, Armando ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Adjuvant chemotherapy; Breast cancer; Herpes infection

Indexed keywords

ACICLOVIR; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; GABAPENTIN; GRANISETRON; MENTHOL; METHOTREXATE; TALC; TAXANE DERIVATIVE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CENTER; CANCER PATIENT; CHEMOTHERAPY INDUCED EMESIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; EARLY CANCER; FEMALE; GENITAL HERPES; HERPES; HERPES LABIALIS; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MOTOR NEUROPATHY; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; SKIN PRURITUS; THERAPY DELAY; VIRUS REACTIVATION; WALKING DIFFICULTY;

ADULT; AGED; ANTHRACYCLINES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CHEMOTHERAPY, ADJUVANT; FEMALE; HERPES SIMPLEX; HERPES ZOSTER; HUMANS; MALE; MIDDLE AGED; TAXOIDS;

EID: 34548069384     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000106065     Document Type: Article

References (13)

1. Mazur MH, Dolin R: Herpes zoster at the NIH: a 20-year experience. Am J Med 1978;63:738-744.
2. Guinee VF, Guido JJ, Pfelzgraf KA, Giacco GG, Legarde C, Durand M, Van der Velden JW, Lowenberg B, Jereb B, Bretsky S: The incidence of herpes zoster in patients with Hodgkin's disease: an analysis of prognostic factors. Cancer 1985;56:612-618.
3. Feld R, Evans WK, DeBoer G: Herpes zoster in patients with small cell carcinoma of the lung receiving combined modality treatment. Ann Intern Med 1980;93:282-283.
4. Feld R, Evans WK, DeBoer G: Herpes zoster in patients with carcinoma of the lung. Am J Med 1982;73:795-801.
5. Di Luzio Paparatti U, Arpinelli F, Visonà G: Herpes zoster and its complications in Italy: an observational survey. J Infect 1999;38:116-120.
6. Donahue JG, Choo PW, Manson JE, et al: The incidence of herpes zoster. Arch Intern Med 1995;155:1605-1609.
7. Opstelten W, Mauritz JW, de Wit NJ, van Wijck AJ, Stalman WA, Van Essen GA: Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam Pract 2000;19:471-475.
8. Insinga RP, Itzler RF, Pellissier JM, Saddier P, Nikas AA: The incidence of herpes zoster in a United States Administrative Database. J Gen Intern Med 2005;20:748-757.
9. Klein JL, Hamm C, Dansey RD, Karanes C, Abella E, Cassells L, Peters WP, Baynes RD: High-dose chemotherapy and CD34-selected peripheral blood progenitor cell transplantation for patients with breast cancer metastatic to bone and/or bone marrow. Bone Marrow Transplant 2001;28:1023-1029.
10. Zambelli A, Montagna D, Da Prada GA, Maccario R, Zibera C, Moretta A, Ponchio L, Lozza L, Baiardi R, Marone P, Della Cuna GR: Evaluation of infectious complications and immune recovery following high-dose chemotherapy (HDC) and autologous peripheral blood progenitor cell transplantation (PBPC-T) in 148 breast cancer patients. Anticancer Res 2002;22:3701-3708.
11. Koc Y, Miller KB, Schenkein DP, Griffith J, Akhtar M, DesJardin J, Snydman DR: Varicella zoster virus infections following allogenic bone marrow transplantation: frequency, risk factors, and clinical outcome. Biol Blood Marrow Transplant 2000;6:644-649.
12. Bilgrami S, Chakraborty NG, Rodriguez-Pinero F, Khan AM, Feingold JM, Bona RD, Edwards RL, Dorsky D, Clive J, Mukherji B, Tutschka PJ: Varicella zoster virus infections associated with high-dose chemotherapy and autologous stem cell rescue. Bone Marrow Transplant 1999;23:469-474.
13. Dunst J, Steil B, Furch S, Fach A, Bormann G, Marsch W: Herpes zoster in breast cancer patients after radiotherapy. Strahlenther Onkol 2000;176:513-516.